References
- Bacmeister L, Schwarzl M, Warnke S, Stoffers B, Blankenberg S, Westermann D, Lindner D. Inflammationand fibrosis in murine models of heart failure. Basic Res Cardiol. 2019;114(3):19.
- Suetomi T, Willeford A, Brand CS, Cho Y, Ross RS, Miyamoto S, Brown JH. Inflammation and NLRP3 Inflammasome activation initiated in response to pressure overload by Ca(2+)/Calmodulin-dependent protein kinase II delta signaling in cardiomyocytes are essential for adverse cardiac remodeling. Circulation. 2018;138(22):2530–44. doi:https://doi.org/10.1161/CIRCULATIONAHA.118.034621.
- Shi W, Ma H, Liu T, Yan D, Luo P, Zhai M, Tao J, Huo S, Guo J, Li C, et al. Inhibition ofInterleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice. J Cell Mol Med. 2020;24(8):4748–61. doi:https://doi.org/10.1111/jcmm.15147.
- Wu L, Zhao F, Dai M, Li H, Chen C, Nie J, Wang P, Wang DW. P2y12 receptor promotes pressure overload-induced cardiac remodeling via plateletdriven inflammation in mice. Hypertension. 2017;70(4):759–69. doi:https://doi.org/10.1161/HYPERTENSIONAHA.117.09262.
- Wang X, Ye Y, Gong H, Wu J, Yuan J, Wang S, Yin P, Ding Z, Kang L, Jiang Q, et al. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice. J Mol Cell Cardiol. 2016;97:180–90.
- Akazawa H, Yabumoto C, Yano M, Kudo-Sakamoto Y, Komuro I. ARB and cardioprotection. Cardiovasc Drugs Ther. 2013;27(2):155–60. doi:https://doi.org/10.1007/s10557-012-6392-2.
- Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, et al. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J Am Coll Cardiol. 2000;35(3):714–21. doi:https://doi.org/10.1016/S0735-1097(99)00594-X.
- Ock S, Ahn J, Lee SH, Park H, Son JW, Oh JG, Yang DK, Lee WS, Kim HS, Rho J, et al. Receptor activator of nuclear factor-kappaB ligand is a novel inducer of myocardial inflammation. Cardiovasc Res. 2012;94(1):105–14. doi:https://doi.org/10.1093/cvr/cvs078.
- Liu M, Yu Y, Jiang H, Zhang L, Zhang PP, Yu P, Jia JG, Chen RZ, Zou YZ, Ge JB. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis. Acta Pharmacol Sin. 2013;34(6):830–36. doi:https://doi.org/10.1038/aps.2013.8.
- Bangert A, Andrassy M, Muller AM, Bockstahler M, Fischer A, Volz CH, Leib C, Goser S, Korkmaz-Icoz S, Zittrich S, et al. Critical role of RAGE and HMGB1 in inflammatory heart disease. Proc Natl Acad Sci USA. 2016;113(2):E155–164. doi:https://doi.org/10.1073/pnas.1522288113.
- Deng M, Tang Y, Li W, Wang X, Zhang R, Zhang X, Zhao X, Liu J, Tang C, Liu Z, et al. The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity. 2018;49(4):740–753.e747. doi:https://doi.org/10.1016/j.immuni.2018.08.016.
- Funayama A, Shishido T, Netsu S, Narumi T, Kadowaki S, Takahashi H, Miyamoto T, Watanabe T, Woo CH, Abe J, et al. Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure. Cardiovasc Res. 2013;99(4):657–64. doi:https://doi.org/10.1093/cvr/cvt128.
- Zhang L, Liu M, Jiang H, Yu Y, Yu P, Tong R, Wu J, Zhang S, Yao K, Zou Y, et al. Extracellularhigh-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure. J Cell Mol Med. 2016;20(3):459–70. doi:https://doi.org/10.1111/jcmm.12743.
- Zhang L, Yang X, Jiang G, Yu Y, Wu J, Su Y, Sun A, Zou Y, Jiang H, Ge J. HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway. Int J Mol Med. 2019;44(3):885–92.
- Haraguchi T, Takasaki K, Naito T, Hayakawa K, Katsurabayashi S, Mishima K, Iwasaki K, Fujiwara M. Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Neurosci Lett. 2009;464(3):151–55. doi:https://doi.org/10.1016/j.neulet.2009.08.043.
- Hagiwara S, Iwasaka H, Hidaka S, Hasegawa A, Koga H, Noguchi T. Antagonist of the type-1 ANG IIreceptor prevents against LPS-induced septic shock in rats. Intensive Care Med. 2009;35(8):1471–78. doi:https://doi.org/10.1007/s00134-009-1545-x.
- Nair AR, Ebenezer PJ, Saini Y, Francis J. Angiotensin II-induced hypertensive renal inflammation ismediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells. Exp Cell Res. 2015;335(2):238–47. doi:https://doi.org/10.1016/j.yexcr.2015.05.011.
- Gao Y, Kang L, Li C, Wang X, Sun C, Li Q, Liu R, Wang J. Resveratrol ameliorates diabetes-induced cardiac dysfunction through AT1R-ERK/p38 MAPK signaling pathway. Cardiovasc Toxicol. 2016;16(2):130–37. doi:https://doi.org/10.1007/s12012-015-9321-3.
- Skurk T, van Harmelen V, Hauner H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol. 2004;24(7):1199–203. doi:https://doi.org/10.1161/01.ATV.0000131266.38312.2e.
- Liu S, Chen HZ, Xu ZD, Wang F, Fang H, Bellanfante O, Chen XL. Sodium butyrate inhibits the productionof HMGB1 and attenuates severe burn plus delayed resuscitation-induced intestine injury via the p38 signaling pathway. Burns. 2019;45(3):649–58. doi:https://doi.org/10.1016/j.burns.2018.09.031.
- Zou Y, Li J, Ma H, Jiang H, Yuan J, Gong H, Liang Y, Guan A, Wu J, Li L, et al. Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice. J Mol Cell Cardiol. 2011;51(5):821–29. doi:https://doi.org/10.1016/j.yjmcc.2011.07.030.
- Ling S, Sun Q, Li Y, Zhang L, Zhang P, Wang X, Tian C, Li Q, Song J, Liu H, et al. CKIP-1 inhibits cardiac hypertrophy by regulating class II histone deacetylase phosphorylation through recruiting PP2A. Circulation. 2012;126(25):3028–40. doi:https://doi.org/10.1161/CIRCULATIONAHA.112.102780.
- Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007;115(11):1398–407. doi:https://doi.org/10.1161/CIRCULATIONAHA.106.643585.
- Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, Thal M, Mackie A, Hoxha E, Ramirez V, et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB.Circulation.2012;126(4):418–29. doi:https://doi.org/10.1161/CIRCULATIONAHA.112.112185.
- Ye Y, Gong H, Wang X, Wu J, Wang S, Yuan J, Yin P, Jiang G, Li Y, Ding Z, et al. Combination treatment with antihypertensive agents enhances the effect of qiliqiangxin on chronic pressure overload-induced cardiac hypertrophy and remodeling in male mice.J Cardiovasc Pharmacol.2015;65(6):628–39. doi:https://doi.org/10.1097/FJC.0000000000000230.
- Burke RM, Lighthouse JK, Mickelsen DM, Small EM. Sacubitril/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts.Circ Heart Fail.2019;12(4):e005565. doi:https://doi.org/10.1161/CIRCHEARTFAILURE.118.005565.
- Iwamoto M, Hirohata S, Ogawa H, Ohtsuki T, Shinohata R, Miyoshi T, Hatipoglu FO, Kusachi S, Yamamoto K, Ninomiya Y. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan. Hypertens Res. 2010;33(12):1305–11. doi:https://doi.org/10.1038/hr.2010.189.
- Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.Hypertension.2004;43(2):499–503. doi:https://doi.org/10.1161/01.HYP.0000111831.50834.93.
- Su FF, Shi MQ, Guo WG, Liu XT, Wang HT, Lu ZF, Zheng QS. High-mobility group box 1 induces calcineurin-mediated cell hypertrophy in neonatal rat ventricular myocytes. Mediators Inflamm. 2012;2012:805149. doi:https://doi.org/10.1155/2012/805149.
- Li L, Zhou N, Gong H, Wu J, Lin L, Komuro I, Ge J, Zou Y. Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertens Res. 2010;33(12):1289–97. doi:https://doi.org/10.1038/hr.2010.182.
- Song E, Jahng JW, Chong LP, Sung HK, Han M, Luo C, Wu D, Boo S, Hinz B, Cooper MA, et al. Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge. Am J Transl Res. 2017;9:2723–35.
- Kumar S, Wang G, Zheng N, Cheng W, Ouyang K, Lin H, Liao Y, Liu J. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis. Hypertension. 2019;73(5):1058–70. doi:https://doi.org/10.1161/HYPERTENSIONAHA.118.12267.
- Guo F, Chen XL, Wang F, Liang X, Sun YX, Wang YJ. Role of angiotensin II type 1 receptor in angiotensinII-induced cytokine production in macrophages. J Interferon Cytokine Res. 2011;31(4):351–61. doi:https://doi.org/10.1089/jir.2010.0073.